Abstract
The few epidemiological studies conducted to date on the heterogeneous group of hereditary spastic paraplegias (HSPs) indicate a prevalence of 1.27–12.1 per 100,000. This study aims to explore the epidemiological, clinical, and genetic variability of HSPs among Sardinians, a population of peculiar ethnicity.A population-based prevalence study was performed in north-western Sardinia between January 2000 and December 2010. Multiple sources were used for case ascertainment. Familial and sporadic cases were diagnosed according to generally accepted criteria, and clinical diagnoses were validated by expert neurological examination. Clinical data and pedigree information were recorded and blood samples drawn for genetic testing.Sixty-seven HSP patients were included in the study: 59 belonged to 11 families with autosomal dominant transmission (AD-HSP), three cases were from two unrelated autosomal recessive families, and the remaining five cases were apparently sporadic. On 31 December 2010, the total crude prevalence was 19.9 per 100,000 (95 % CI 18.4–21.4), while the crude prevalence of AD-HSP was 17.5 (24.4 M, 15.7 F; M:F ratio 1.55). The mean age at examination was 48.4 years, and the mean age at onset of HSP was 36.6 years. A molecular diagnosis was obtained in 82.1 % of the cases (52 cases with mutations in SPAST/SPG4, two in SPG7, and one in SPG11).The prevalence of HSP among Sardinians is high compared with other Western European populations. The multiple search strategy used in this study and the specific socio-demographic characteristics of Sardinians may account for this finding.
Similar content being viewed by others
References
Depienne C, Stevanin G, Brice A, Durr A (2007) Hereditary spastic paraplegias: an update. Curr Opin Neurol 20:674–680
Hanein S, Martin E, Boukhris A et al (2008) Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 82:992–1002
Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155
Finsterer J, Löscher W, Quasthoff S et al (2012) Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 318:1–18
Polo JM, Calleja J, Combarros O, Berciano J (1991) Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain 114:855–866
Elleuch N, Bouslam N, Hanein S et al (2007) Refinement of the SPG15 candidate interval and phenotypic heterogeneity in three large Arab families. Neurogenetics 8:307–315
Stevanin G, Azzedine H, Denora P et al (2008) Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131:772–784
Boukhris A, Stevanin G, Feki I et al (2008) Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15 and further genetic heterogeneity. Arch Neurol 65:393–402
Skre H (1974) Hereditary spastic paraplegia in Western Norway. Clin Genet 6:165–183
Sridharan R, Radhakrishnan K, Ashok PP, Mousa ME (1985) Prevalence and pattern of spinocerebellar degenerations in northeastern Libya. Brain 108:831–843
Brignolio F, Leone M, Tribolo A et al (1986) Prevalence of hereditary ataxias and paraplegias in the province of Torino, Italy. Ital J Neurol Sci 7:431–435
Filla A, De Michele G, Marconi R et al (1992) Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J Neurol 239:351–353
Leone M, Bottacchi E, D’Alessandro G, Kustermann S (1995) Hereditary ataxias and paraplegias in Valle d’Aosta, Italy: a study of prevalence and disability. Acta Neurol Scand 91:183–187
Silva MC, Coutinho P, Pinheiro CD, Neves JM, Serrano P (1997) Hereditary ataxias and spastic paraplegias : methodological aspects of a prevalence study in Portugal. J Clin Epidemiol 50:1377–1384
McMonagle P, Webb S, Hutchinson M (2002) The prevalence of pure autosomal dominant hereditary spastic paraparesis in the island of Ireland. J Neurol Neurosurg Psychiatry 72:43–46
Braschinshy M, Lüüs SM, Gross-Paju K, Haldre S (2009) The prevalence of hereditary spastic paraplegia and the occurrence of SPG4 mutations in Estonia. Neuroepidemiology 32:89–93
Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM (2009) Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population based study. Brain 132:1577–1588
Ruano L, Loureiro JL et al (2013) Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol 22:1–10
Pugliatti M, Rosati G, Carton H et al (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13:700–722
Pugliatti M, Cossu P, Sotgiu S, Rosati G, Riise T (2009) Clustering of multiple sclerosis, age of onset and gender in Sardinia. J Neurol Sci 286:6–13
Contu D, Morelli L, Santoni F et al (2008) Y-chromosome based evidence for pre-neolithic origin of the genetically homogeneous but diverse Sardinian population: inference for association scans. PLoS ONE 3:e1430
DemoIstat http://demo.istat.it/pop2010/index.html. Accessed 24 October 2012
Fink JK, Heiman-Patterson T, Bird T, Hereditary Spastic Paraplegia Working Group et al (1996) Hereditary spastic paraplegia: advances in genetic research. Neurology 46:1507–1514
Reid E (1997) Pure hereditary spastic paraplegia. J Med Genet 34:499–503
Mc Dermott CJ, Burness CE, Kirby J et al (2006) Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology 67:45–51
Associazione Italiana Vivere la Paraparesi Spastica (VIPS). http://www.vipsonlus.it. Accessed 6 November 2012
Tallaksen CM (2003) SPATAX-European Network for hereditary spinocerebellar degenerative disorders. Acta Neurol Scand 107:433–434
Schüle R, Holland-Letz Klimpe S (2006) The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 67:430–434
Fonknechten N, Mavel D, Byrne P et al (2000) Spectrum of SPG4 mutations in autosomal dominant hereditary spastic paraplegia. Hum Mol Genet 9:637–644
Moroni A, Anelli A, Anghinetti W, Lucchetti E, Rossi O, Siri E (1972) La consanguineità umana nell’isola di Sardegna dal secolo XVIII al secolo XX. Ateneo Parmese 8:69–82
Gialluisi A, Incollu S, Pippucci T et al (2013) The homozygosity index (HI) approach reveals high allele frequency for Wilson disease in the Sardinian population. Eur J Hum Genet Epub 13 Mar 2013
Fink JK (2006) Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 6:65–76
Tallaksen CM, Dürr A, Brice A (2000) Recent advances in hereditary spastic paraplegia. Curr Opin Neurol 14:457–463
Dürr A, Brice A, Serdaru M et al (1994) The phenotype of “pure” autosomal dominant spastic paraplegia. Neurology 44:1274–1277
Santorelli FM, Patrono C, Fortini D et al (2000) Intrafamilial variability in hereditary spastic paraplegia associated with an SPG4 gene mutation. Neurology 55:702–705
Acknowledgments
We acknowledge for their financial support: Telethon Italy (grant n. GPP10121A to F.M.S) and the Federazione Italiana Donne Arti Professioni Affari (International Federation of Business and Professional Women, FIDAPA), Porto Torres, Italy.
Dr. Nino Tedde is fully acknowledged for his contribution in informing GPs in the study area on study aims and for supporting us throughout the study. The authors also thank the Associazione Vivere la Paraparesi Spastica Onlus-VIPS (www.vipsonlus.it) for their continuous support, and Dr. Catherine J. Wrenn for her expert editorial assistance.
Conflicts of interest
The authors declare that they have not conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Racis, L., Tessa, A., Di Fabio, R. et al. The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy. J Neurol 261, 52–59 (2014). https://doi.org/10.1007/s00415-013-7151-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-013-7151-4